CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced ...

Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970 million biobucks for licensing rights to Kelun-Biotech and Harbour BioMed’s clinical ...

YD Bio Limited ('YD Bio” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that the ...

Speculative investors and patience rarely go hand in hand. Nevertheless, if you’re looking to invest in the small-cap biotech sector, patience is a requirement. Most, if not all, of these companies ...

HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has entered into a non-binding memorandum (the ...

From expanding partnerships to advancing trials, Mainz Biomed NV (NASDAQ:MYNZ), the molecular genetics diagnostic company, had a busy 2024 – which appears to have shown in its revenue growth. The ...

Biotech stocks toppled Thursday after President Donald Trump announced broad global tariffs. A fact sheet from the White House says pharmaceutical products will be exempt from the higher ...

Undergraduate enrollment in biomedical majors rose to nearly 642,500, increasing 3.7% in 2025 compared to 3.1% in 2024. And ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A judge has denied BioMed Realty ...

CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (LFCR) (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and ...